The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 30 January 2006 doi:10.1084/jem.20052033
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 2, 393-400
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3039K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuiji, M.
Right arrow Articles by Wardemann, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuiji, M.
Right arrow Articles by Wardemann, H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

 A checkpoint for autoreactivity in human IgM+ memory B cell development

Makoto Tsuiji1, Sergey Yurasov1,2, Klara Velinzon1, Saskia Thomas4, Michel C. Nussenzweig1,3, and Hedda Wardemann1

1 Laboratory of Molecular Immunology, The Rockefeller University, 2 Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, and 3 Howard Hughes Medical Institute, New York, NY 10021
4 FU-Berlin, Department of Biology, Chemistry, and Pharmacy, 14195 Berlin, Germany

CORRESPONDENCE Hedda Wardemann: wardemh{at}rockefeller.edu

Autoantibodies are removed from the repertoire at two checkpoints during B cell development in the bone marrow and the periphery. Despite these checkpoints, up to 20% of the antibodies expressed by mature naive B cells in healthy humans show low levels of self-reactivity. To determine whether self-reactive antibodies are also part of the antigen-experienced memory B cell compartment, we analyzed recombinant antibodies cloned from single circulating human IgM+ memory B cells. Cells expressing antibodies specific for individual bacterial polysaccharides were expanded in the IgM+ memory compartment. In contrast, B cells expressing self-reactive and broadly bacterially reactive antibodies were removed from the repertoire in the transition from naive to IgM+ memory B cell. Selection against self-reactive antibodies was implemented before the onset of somatic hypermutation. We conclude that a third checkpoint selects against self-reactivity during IgM+ memory B cell development in humans.

Abbreviations used: ANA, antinuclear antibody; CVID, common variable immunodeficiency; FWR, framework region; HEL, Hen egg lysozyme; IFA, indirect immunofluorescence assay; MZ, marginal zone; mSpA, modified Staphylococcus aureus protein A; SpA, Staphylococcus aureus protein A; T-I, T cell–independent; T-D, T cell–dependent.

M.C. Nussenzweig and H. Wardemann contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS